HomePCSA • NASDAQ
add
Processa Pharmaceuticals Inc
Previous close
$0.22
Day range
$0.21 - $0.23
Year range
$0.15 - $1.58
Market cap
11.38M USD
Avg Volume
7.94M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.95M | 28.19% |
Net income | -3.93M | -30.68% |
Net profit margin | — | — |
Earnings per share | -0.25 | 75.25% |
EBITDA | -3.95M | -28.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 8.18M | 7.64% |
Total liabilities | 2.07M | 31.53% |
Total equity | 6.11M | — |
Shares outstanding | 50.35M | — |
Price to book | 1.49 | — |
Return on assets | -152.05% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.93M | -30.68% |
Cash from operations | -2.27M | 32.14% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 4.04M | 220.61% |
Free cash flow | -806.39K | 64.37% |
About
Founded
2011
Headquarters
Website
Employees
10
